NO20044321L - Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase - Google Patents

Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase

Info

Publication number
NO20044321L
NO20044321L NO20044321A NO20044321A NO20044321L NO 20044321 L NO20044321 L NO 20044321L NO 20044321 A NO20044321 A NO 20044321A NO 20044321 A NO20044321 A NO 20044321A NO 20044321 L NO20044321 L NO 20044321L
Authority
NO
Norway
Prior art keywords
piperidinylamine
piperazinyl
acid amides
sulfamic acid
inhibitors
Prior art date
Application number
NO20044321A
Other languages
English (en)
Inventor
Philipp Lehr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0207500A external-priority patent/GB0207500D0/en
Priority claimed from GB0225679A external-priority patent/GB0225679D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044321L publication Critical patent/NO20044321L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Det er beskrevet piperazinyl- eller piperidinylaminsulfaminsyreamider og deres anvendelse for fremstilling av et medikament for sykdommer formidlet ved virkningen av steroidsulfatase.
NO20044321A 2002-03-28 2004-10-12 Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase NO20044321L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0207500A GB0207500D0 (en) 2002-03-28 2002-03-28 Organic compounds
GB0225679A GB0225679D0 (en) 2002-11-04 2002-11-04 Organic compounds
PCT/EP2003/003214 WO2003082842A1 (en) 2002-03-28 2003-03-27 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase

Publications (1)

Publication Number Publication Date
NO20044321L true NO20044321L (no) 2004-10-12

Family

ID=28676499

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044321A NO20044321L (no) 2002-03-28 2004-10-12 Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase

Country Status (20)

Country Link
US (2) US7439362B2 (no)
EP (1) EP1492782A1 (no)
JP (1) JP4580652B2 (no)
KR (1) KR20040094877A (no)
CN (1) CN1293065C (no)
AR (1) AR039156A1 (no)
AU (1) AU2003226732B2 (no)
BR (1) BR0308795A (no)
CA (1) CA2480686A1 (no)
CO (1) CO5640113A2 (no)
IL (1) IL164267A0 (no)
MX (1) MXPA04009453A (no)
MY (1) MY136880A (no)
NO (1) NO20044321L (no)
NZ (1) NZ535617A (no)
PE (1) PE20040167A1 (no)
PL (1) PL372602A1 (no)
RU (1) RU2329258C2 (no)
TW (1) TW200306806A (no)
WO (1) WO2003082842A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0505539D0 (en) * 2005-03-17 2005-04-27 Novartis Ag Organic compounds
GB0505541D0 (en) * 2005-03-17 2005-04-27 Novartis Ag Organic compounds
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
US20100204146A1 (en) 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
CN109069658B (zh) 2016-02-08 2022-10-14 西纳福克斯股份有限公司 用于靶向her2肿瘤的具有改善的治疗指数的抗体-缀合物以及用于改善抗体-缀合物的治疗指数的方法
CN109152844B (zh) * 2016-02-08 2022-11-22 西纳福克斯股份有限公司 用于治疗的含有磺酰胺接头的生物缀合物
WO2017137423A1 (en) 2016-02-08 2017-08-17 Synaffix B.V. Improved sulfamide linkers for use in bioconjugates
AU2017367086A1 (en) * 2016-11-29 2019-07-18 Epizyme, Inc. Compounds containing a sulfonic group as KAT inhibitors
EP3983388A1 (en) * 2019-06-12 2022-04-20 Nodthera Limited Sulfonamide derivatives and uses thereof
CN110590896B (zh) * 2019-11-04 2022-08-30 上海高准医药有限公司 雌酚酮硫酸酯哌嗪的制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US478328A (en) * 1892-07-05 Glass-heating oven
US71516A (en) * 1867-11-26 William b
US51547A (en) * 1865-12-19 Improvement in guide and tuck-marker for sewing-machines
US89089A (en) * 1869-04-20 Improved car-coupling
US183459A (en) * 1876-10-17 Improvement in hinges
US876846A (en) * 1907-05-28 1908-01-14 Stephen W Smith Road-machine.
US1122242A (en) * 1912-05-13 1914-12-29 Sanitary Can Company Can-body-feeding device.
US2103610A (en) * 1935-04-30 1937-12-28 Sofal Ltd Alloy steels
DE876846C (de) * 1943-06-01 1953-05-18 Bayer Ag Verfahren zur Herstellung von Abkoemmlingen des Sulfondiamids
US3004487A (en) * 1959-12-07 1961-10-17 Bank Of America Nat Trust & Savings Ass Imprinters
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
FR2510106A1 (fr) 1981-07-27 1983-01-28 Rhone Poulenc Agrochimie Composes herbicides derives d'acides phenoxybenzoiques, et leurs procedes de preparation et d'utilisation
DK101683A (da) * 1982-03-12 1983-09-13 Duphar Int Res Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf
US5238923A (en) * 1989-05-26 1993-08-24 Warner-Lambert Company Amino-substituted heterocycles as renin inhibitors
US5256632A (en) * 1990-05-30 1993-10-26 Bayer Aktiengesellschaft Herbicidal sulphonylated carboxamides
IL99537A (en) 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
FR2716882B1 (fr) * 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
US5464788A (en) 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5783582A (en) 1994-07-20 1998-07-21 Merck & Co., Inc. Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone
EP0784612A1 (en) 1994-10-04 1997-07-23 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
AU7626496A (en) 1995-12-01 1997-06-27 Ciba-Geigy Ag Heteroaryl compounds
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621482A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6204268B1 (en) 1997-04-14 2001-03-20 Cor Therapeutics, Inc Selective factor Xa inhibitors
ES2300151T3 (es) 1998-09-22 2008-06-01 Astellas Pharma Inc. Derivados de cianofenilo.
CA2362778A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1185512A2 (en) 1999-05-24 2002-03-13 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa
JP4320089B2 (ja) * 1999-07-06 2009-08-26 あすか製薬株式会社 フェニルスルファメート誘導体
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
HU229494B1 (en) 2000-05-04 2014-01-28 Basf Ag Uracil substituted phenyl sulfamoyl carboxamides
BR0210391A (pt) * 2001-06-12 2004-06-15 Elan Pharm Inc Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
KR20040013090A (ko) 2001-07-02 2004-02-11 아스트라제네카 아베 케모킨 수용체 활성의 조절자로서 유용한 피페리딘 유도체

Also Published As

Publication number Publication date
PL372602A1 (en) 2005-07-25
CO5640113A2 (es) 2006-05-31
NZ535617A (en) 2006-04-28
JP2005526812A (ja) 2005-09-08
EP1492782A1 (en) 2005-01-05
MXPA04009453A (es) 2005-01-25
MY136880A (en) 2008-11-28
AR039156A1 (es) 2005-02-09
CN1646509A (zh) 2005-07-27
US20090042899A1 (en) 2009-02-12
BR0308795A (pt) 2005-01-18
WO2003082842A1 (en) 2003-10-09
US20060052393A1 (en) 2006-03-09
TW200306806A (en) 2003-12-01
AU2003226732A1 (en) 2003-10-13
KR20040094877A (ko) 2004-11-10
CN1293065C (zh) 2007-01-03
PE20040167A1 (es) 2004-05-26
US7439362B2 (en) 2008-10-21
JP4580652B2 (ja) 2010-11-17
RU2329258C2 (ru) 2008-07-20
AU2003226732B2 (en) 2006-12-21
CA2480686A1 (en) 2003-10-09
RU2004131822A (ru) 2005-07-10
IL164267A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
NO20051726L (no) Pyrimidinonderivaer som terapeutiske midler ovenfor akutte og kroniske inflammasjons-, iskemiske og remodeleringsprosesser
DK1347955T3 (da) Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DE50312034D1 (de) Liposomale glucocorticoide
NO20076206L (no) Kombinasjon av PDE4 inhibitor romflumilast og et tetrahydrobioterin-derivativ
WO2005044199A3 (en) Combination of proton pump inhibitor and sleep aid
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
NO20076616L (no) 17beta-HSD1- og STS-inhibitorer
NO20055496D0 (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
NO20023786L (no) Heteroaromatiske karboksamidderivater og deres anvendelse som inhibitorer av enzymet IKK-2
NO20051107L (no) Substituerte tienylhydroksaminsyrer og deres anvendelse til behandling av sykdommer forbundet med enzymatisk histondeacetylueaktivitet
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NO20045281L (no) Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
HRP20090498T1 (hr) Kombinacija r,r-glikopirolata, roliprama i budesonida za liječenje upalnih oboljenja
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
SE0101932D0 (sv) Pharmaceutical combinations
NO20044321L (no) Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
DK1531675T3 (da) Midler, som indeholder carboxylsyre, og deres anvendelse i plantedyrkning
NO20080781L (no) GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application